Table 4 Scenario analyses on lifetime haemophilia burden for 2011 in Belgium
From: The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease
Scenario | 1.5% time discounting, no age weighting | 3% time discounting, no age weighting | 3% time discounting, age weighting | |||
|---|---|---|---|---|---|---|
| Â | DALY | DALY per case | DALY | DALY per case | DALY | DALY per case |
| Â | (95% CrI) | (95% CrI) | (95% CrI) | (95% CrI) | (95% CrI) | (95% CrI) |
Haemophilia (total) | 72 (46–108) | 5 (4–8) | 40 (26–58) | 3 (2–4) | 47 (31–69) | 4 (3–5) |
 Severe | 47 (21–82) | 8 (7–9) | 25 (11–43) | 4 (4–5) | 30 (14–51) | 5 (5–5) |
 Moderate | 15 (14–16) | 6 (3–13) | 8 (8–9) | 3 (2–7) | 10 (9–11) | 4 (2–9) |
 Mild | 10 (9–11) | 2 (1–5) | 6 (6–7) | 1 (1–3) | 7 (7–8) | 2 (1–4) |